Related Experiment Video
Updated: Jul 31, 2026
Optimized Fibrin Gel Bead Assay for the Study of Angiogenesis
Published on: April 29, 2007
Setting up of an original computer-assisted methodology to characterize in vitro drug-induced anti-angiogenic effects
S Farinelle1, C Dehauwer, F Darro
1Laboratoire d'Histologie, Faculté de Medecine, Université Libre de Bruxelles, Brussels, Belgium.
Abstract:
The development of angiogenesis within a tumor brings on a sequence of extremely complex molecular events. We have developed a methodology which enables a wide set of biological parameters to be quantitatively determined in the field of anti-angiogenesis pharmacology. This methodology which includes a video cell tracking device, is unique because it offers the possibility of evaluating the specific influence of a given compound with potential anti-angiogenic properties on cell cycle kinetics, cell death, global cell line growth, and cell motility. We chose TNP-470, a synthetic analogue of fumagilin, to test our methodology on HUVEC cell lines taken from various human umbilical cord veins. The experiments carried out with TNP-470 did not confirm all the data reported in the literature. Our results show that i) TNP-470 could be considered as a cytotoxic agent; ii) this compound had an apparently marginal cytostatic effect; and iii) it did not increase the apoptosis level. Our methodology also revealed that the HUVEC cell lines are very heterogeneous in terms of different biological parameters. This highlights the problem of the reproductibility of the result.
Insights
This study introduces a new method to assess anti-angiogenesis drug effects on tumor cells. The developed technique revealed TNP-470 is cytotoxic, not cytostatic, and highlighted HUVEC cell line heterogeneity.
Area of Science:
- Pharmacology
- Cancer Biology
- Cell Biology
Background:
- Tumor angiogenesis involves complex molecular processes.
- Anti-angiogenesis therapies aim to inhibit tumor blood vessel formation.
- Evaluating drug effects requires precise quantitative biological parameter assessment.
Purpose of the Study:
- To develop and validate a novel methodology for quantitatively assessing anti-angiogenic compounds.
- To evaluate the effects of TNP-470 on human umbilical vein endothelial cell (HUVEC) lines.
- To investigate TNP-470's impact on cell cycle, death, growth, and motility.
Main Methods:
- Development of a quantitative methodology incorporating video cell tracking.
- Application of the methodology to assess TNP-470 effects on HUVEC cell lines.
- Analysis of cell cycle kinetics, cell death, proliferation, and migration.
Main Results:
- TNP-470 demonstrated cytotoxic effects rather than cytostatic effects.
- Apoptosis levels were not significantly increased by TNP-470 treatment.
- Significant heterogeneity was observed among HUVEC cell lines regarding biological parameters, impacting reproducibility.
Conclusions:
- The developed methodology provides a comprehensive approach to evaluate anti-angiogenic agents.
- TNP-470's primary effect is cytotoxicity, contradicting some literature.
- HUVEC cell line heterogeneity poses challenges for result reproducibility in anti-angiogenesis research.
More Related Videos
09:24Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells
Published on: September 18, 2019
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021